Logo image
Pulmonary arterial hypertension
Journal article

Pulmonary arterial hypertension

Srinivas Murali
Current opinion in critical care, v 12(3)
Jun 2006
PMID: 16672782

Abstract

Antihypertensive Agents - therapeutic use Drug Therapy, Combination Endothelin-1 - antagonists & inhibitors Endothelin-1 - therapeutic use Epoprostenol - therapeutic use Evidence-Based Medicine Humans Hypertension, Pulmonary - drug therapy Hypertension, Pulmonary - physiopathology Nitric Oxide Pulmonary Artery - physiopathology Randomized Controlled Trials as Topic
The prevalence of pulmonary arterial hypertension is rising worldwide. Significant progress in our understanding of the pathobiology of pulmonary arterial hypertension has resulted in a shift from vasodilator therapy to the development of specific drugs targeting seminal molecular derangements of this disorder. This review highlights the recent advances in treatment and provides directions for the future care. Induction of endothelin-1 and decreased transcription of nitric oxide and prostacyclin leads to pulmonary vasoconstriction that triggers several downstream molecular events which result in pulmonary vascular remodeling. Treatment with endothelin receptor antagonists, prostanoids and phosphodiesterase-5 inhibitors that prevent breakdown of cGMP have all demonstrated benefits in prospective, randomized, controlled trials of pulmonary arterial hypertension patients. Future strategies will combine these therapies to explore whether targeting more than one pathway provides synergistic long-term benefit. Treatment guidelines developed by the American College of Chest Physicians aim to ensure that evidence-based approaches are practiced. Because of genetic heterogeneity in treatment effects and outcomes among patients, pharmacogenetics which will study polymorphisms that modulate the response to treatment will enable physicians to deliver cost-effective, tailored treatments for all pulmonary arterial hypertension patients in the future.

Metrics

6 Record Views
16 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Critical Care Medicine
Logo image